What is the most appropriate regimen for untreated Waldenström macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Res
Main Authors: Sekiguchi, Naohiro, Hamano, Airi, Kitagawa, Tomoko, Ito, Kenichi, Hirano, Kazuhiko, Yamada, Kazuaki
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Assuntos:
Letters to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614101/
https://ncbi.nlm.nih.gov/pubmed/31309097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2019.54.2.153
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados